SlideShare a Scribd company logo
Strategie di test
per la valutazione di
skin e eye irritation
Costanza Rovida
CAAT Europe
REACH mastery
costanza.rovida@chimici.it
Slide 1 of 60
Slide 3 of 60
Slide 2 of 60
www.echemportal.org
Tipo di test eseguito
170
228
188
142
166 168
296
134
38
29
48
133
365
152
350
167
0
100
200
300
400
500
600
700
2006 2007 2008 2009 2010 2011 2012 2013
Skin corrosion/irritation
in vivo in vitro
Slide 2 of 60
www.echemportal.org
Tipo di test eseguito
144
216
160
109
312
167
284
169
12
21
38
91
268
117
284
139
0
50
100
150
200
250
300
350
2006 2007 2008 2009 2010 2011 2012 2013
in vivo
in vitro
Eye corrosion/irritation
I risultati negativi di un test in vitro
non sono accettati
dagli enti regolatori e
vanno obbligatoriamente sempre
confermati in vivo
1.4. In vitro methods
…….
If the results obtained from the use of such in vitro methods do not indicate a
certain dangerous property, the relevant test shall nevertheless be carried out at
the appropriate tonnage level to confirm the negative result, unless testing is not
required in accordance with Annexes VII to X or the other rules in this Annex.
Such confirmation may be waived, if the following conditions are met:
(1) results are derived from an in vitro method whose scientific validity has been
established by a validation study, according to internationally agreed validation
principles;
(2) results are adequate for the purpose of classification and labelling and/or risk
assessment; and
(3) adequate and reliable documentation of the applied method is provided.
Page 32
Other official documents
http://echa.europa.eu/documents/10162/21650280/oecd_test_guidelines_skin_irritation_en.pdf
Report EUR 26797 EN
http://publications.jrc.ec.europa.eu/repository/handle/111111111/32662
OECD 404:
Description of the evaluation
and testing strategy
• Step 1: Evaluation of existing human and animal data
• Step 2: Analysis of structure activity relationships
(SAR)
• Step 3: Physicochemical properties and
chemical reactivity
• Step 4: Dermal toxicity
• Step 5 and 6: Results from in vitro or ex vivo tests
• Step 6 and 7: In vivo test in rabbits
Slide 4 of 60
1. Human data:
a. Occupational exposure
b. (consumer exposure)
2. Old animal data:
a. Impurities
b. GLP
Valutazione dei dati esistenti
Raccolta
di tutte le informazioni disponibili
• Step 3: Physicochemical properties and chemical
reactivity
• Step 4: Dermal toxicity (and other data)
http://chem.sis.nlm.nih.gov/chemidplus/
Raccolta
di tutte le informazioni disponibili
Analisi della
structure activity relationships (SAR)
Proprietà chimico-fisiche e reattività chimica
Slide 5 of 60
Skin irritation Eye irritation
Not irritant Not irritant
Category 2 – H315
Causes skin irritation
Category 2 – H319
Causes serious eye irritation
Category 1 – H314
Causes severe skin burns
and eye damage
Category 1 – H318
Causes serious eye damage
Category 1A / 1B / 1C (Packing group I, II, III)1
Skin irritation Eye irritation
Not irritant Not irritant
Not irritant Category 2 - H319
Causes serious eye irritation
Category 2 – H315
Causes skin irritation
Category 2 - H319
Causes serious eye irritation
Category 2 – H315
Causes skin irritation
Category 1- H318
Causes serious eye damage
Category 1 – H314
Causes severe skin burns and eye damage
• I dati esistenti, le proprietà chimico-fisiche (sperimentali o stimate)
e lo studio SAR permettono una previsione preliminare della
possibilita per una sostanza di essere irritante o corrosiva per la
pelle e per gli occhi.
Slide 5 of 60
CORROSIVO? IRRITANTE?
TOP DOWN APPROACH
(irritation category)
BOTTOM UP APPROACH
Top Down e Bottom up
Esempio di strategia
Esempio: Thioanisole
methyl phenyl sulphide
EC 202-878-2
CAS 100-68-5
https://eurl-ecvam.jrc.ec.europa.eu/laboratories-research/predictive_toxicology/information-sources/qsar-document-area/Evaluation_of_Skin_Irritation_QSARs.pdf
Thioanisole and QSAR Toolbox
Thioanisole and similar substances:
Anisole
EUH066 (repeated exposure may cause skin dryness or cracking) Observed in an in vivo skin irritation study.
Thioanisole: mild irritant?
As described in the ECHA database
Guideline B46: In Vitro Skin Irritation:
Reconstructed Human Epidermis Model Test
GLP Study
Test substance: 10 µL undiluted
Duration of treatment:
15 minutes followed by washing and incubation for 42 hours at 37°C
Test animal: human
Species and strain, number of animals: not relevant
control animals: Other, negative control tissues treated with PBS;
positive control tissues treated with 5% SDS
Results: The relative mean tissue viability obtained after 15 minutes treatment
compared to the negative controls was 11% (< 50%)
H315: Causes skin irritation
Thioanisole: eye irritant?
As described in the ECHA database
OECD Guideline 437:
Bovine Corneal Opacity and Permeability (BCOP)
GLP Study
Test substance: 750 µL undiluted
Duration of treatment: 10 minutes
Test animal: Bovine
Species and strain, number of animals: not relevant
Results: IVS range from 2.9 and 4.8, average 3.9
H318: Causes eye irritation
I risultati del BCOP sono molto vicini alla non classificazione. Questo, in
teoria, dovrebbe indurre nuovi test di valutazione.
Tuttavia, questa sostanza è già classificata irritante per la pelle.
Thioanisole: corrosive?
As described in the ECHA database
Guideline B40: In Vitro Skin corrosion:
In vitro Skin Corrosion: Human Skin Model Test
GLP Study
Test substance: 50 µL undiluted
Duration of treatment: 3 minutes and 1 hour
Test animal: human
Species and strain: not relevant
number of animals: 4 tissues
Results: 3 minutes: viability 50%
1 hour: viability 59%
Not Corrosive, Classification H315 confirmed
Conclusions
Considerare le richieste regolatorie
Non esiste una strategia universale: anche la valutazione più semplice va adattata
alla sostanza (miscela) specifica e ad un determinato uso, nonchè ambito di
applicazione.
La valutazione di una sostanza va fatta in modo globale, e non endpoint per
endpoint
Le conclusioni sono una valutazione di tutti I dati disponibili, e non solo una mera
somma delle conclusioni dei singoli studi.
Un occhio anche ai costi e alla semplificazione dell'approccio
Ancora troppo basata sul giudizio degli esperti
Skin eye irritation

More Related Content

What's hot

In process and finished products quality control for
In process  and finished products quality control forIn process  and finished products quality control for
In process and finished products quality control for
VidyaNani
 
Evaluation of parenterals products
Evaluation of parenterals productsEvaluation of parenterals products
Evaluation of parenterals products
D.R. Chandravanshi
 
inprocess quality control test
inprocess quality control testinprocess quality control test
inprocess quality control test
DurgaLakshmi24
 
NOVEL IPQCL AND FPQC TEST FOR OPTHALMIC PREPARATION AS PER IP, BP A...
NOVEL IPQCL AND FPQC   TEST   FOR OPTHALMIC PREPARATION   AS   PER   IP, BP A...NOVEL IPQCL AND FPQC   TEST   FOR OPTHALMIC PREPARATION   AS   PER   IP, BP A...
NOVEL IPQCL AND FPQC TEST FOR OPTHALMIC PREPARATION AS PER IP, BP A...
roshan telrandhe
 
IPQC tests for Parenterals
IPQC tests for ParenteralsIPQC tests for Parenterals
IPQC tests for Parenterals
praptipattanayak
 
Formulation and development of parenterals
Formulation and development of parenteralsFormulation and development of parenterals
Formulation and development of parenterals
Sai Datri Arige
 
Quality control test for parentrals
Quality  control test for parentralsQuality  control test for parentrals
Quality control test for parentrals
urooj001
 
Quality control of parentrals
Quality control of parentralsQuality control of parentrals
in process quality control test for ophthalmic and parenterals
in process quality control test for ophthalmic and parenterals in process quality control test for ophthalmic and parenterals
in process quality control test for ophthalmic and parenterals
Henisha Patel
 
Quality Control Of Parenteral Preparations
Quality Control Of Parenteral PreparationsQuality Control Of Parenteral Preparations
Quality Control Of Parenteral Preparations
Qurat Ul Ain
 
Qc for sterile pharmaceutical product
Qc for sterile pharmaceutical productQc for sterile pharmaceutical product
Qc for sterile pharmaceutical product
Aniket Gholap
 
Evaluation of Parentrals
Evaluation of ParentralsEvaluation of Parentrals
Evaluation of Parentrals
Pallavi Kurra
 
quality control test of parenteral product
quality control test of parenteral productquality control test of parenteral product
quality control test of parenteral product
Hujaipha Ansari
 
Endotoxin testing
Endotoxin testing Endotoxin testing
Endotoxin testing
Gibraltar Laboratories
 
Quality control tests for parenterals ppt
Quality  control  tests  for  parenterals pptQuality  control  tests  for  parenterals ppt
Quality control tests for parenterals ppt
suraj p rajan
 
Parentral
ParentralParentral
Parentral
Maha Kiran
 
Visual inspection of parenteral products
Visual inspection of parenteral productsVisual inspection of parenteral products
Visual inspection of parenteral products
Sambhujyoti Das
 
Quality control tests for containers
Quality control tests for containersQuality control tests for containers
Ipqc for parenterals
Ipqc for parenteralsIpqc for parenterals
Ipqc for parenteralsceutics1315
 

What's hot (19)

In process and finished products quality control for
In process  and finished products quality control forIn process  and finished products quality control for
In process and finished products quality control for
 
Evaluation of parenterals products
Evaluation of parenterals productsEvaluation of parenterals products
Evaluation of parenterals products
 
inprocess quality control test
inprocess quality control testinprocess quality control test
inprocess quality control test
 
NOVEL IPQCL AND FPQC TEST FOR OPTHALMIC PREPARATION AS PER IP, BP A...
NOVEL IPQCL AND FPQC   TEST   FOR OPTHALMIC PREPARATION   AS   PER   IP, BP A...NOVEL IPQCL AND FPQC   TEST   FOR OPTHALMIC PREPARATION   AS   PER   IP, BP A...
NOVEL IPQCL AND FPQC TEST FOR OPTHALMIC PREPARATION AS PER IP, BP A...
 
IPQC tests for Parenterals
IPQC tests for ParenteralsIPQC tests for Parenterals
IPQC tests for Parenterals
 
Formulation and development of parenterals
Formulation and development of parenteralsFormulation and development of parenterals
Formulation and development of parenterals
 
Quality control test for parentrals
Quality  control test for parentralsQuality  control test for parentrals
Quality control test for parentrals
 
Quality control of parentrals
Quality control of parentralsQuality control of parentrals
Quality control of parentrals
 
in process quality control test for ophthalmic and parenterals
in process quality control test for ophthalmic and parenterals in process quality control test for ophthalmic and parenterals
in process quality control test for ophthalmic and parenterals
 
Quality Control Of Parenteral Preparations
Quality Control Of Parenteral PreparationsQuality Control Of Parenteral Preparations
Quality Control Of Parenteral Preparations
 
Qc for sterile pharmaceutical product
Qc for sterile pharmaceutical productQc for sterile pharmaceutical product
Qc for sterile pharmaceutical product
 
Evaluation of Parentrals
Evaluation of ParentralsEvaluation of Parentrals
Evaluation of Parentrals
 
quality control test of parenteral product
quality control test of parenteral productquality control test of parenteral product
quality control test of parenteral product
 
Endotoxin testing
Endotoxin testing Endotoxin testing
Endotoxin testing
 
Quality control tests for parenterals ppt
Quality  control  tests  for  parenterals pptQuality  control  tests  for  parenterals ppt
Quality control tests for parenterals ppt
 
Parentral
ParentralParentral
Parentral
 
Visual inspection of parenteral products
Visual inspection of parenteral productsVisual inspection of parenteral products
Visual inspection of parenteral products
 
Quality control tests for containers
Quality control tests for containersQuality control tests for containers
Quality control tests for containers
 
Ipqc for parenterals
Ipqc for parenteralsIpqc for parenterals
Ipqc for parenterals
 

Viewers also liked

Skin phototoxicity-of-cosmetic-formulations-containing-photounstable-and-phot...
Skin phototoxicity-of-cosmetic-formulations-containing-photounstable-and-phot...Skin phototoxicity-of-cosmetic-formulations-containing-photounstable-and-phot...
Skin phototoxicity-of-cosmetic-formulations-containing-photounstable-and-phot...
Marília Tiemi
 
Pyrogen and its various test
Pyrogen and its various testPyrogen and its various test
Pyrogen and its various test
Prachi Barbhaiya
 
Alternative and integrated testing strategies
Alternative and integrated testing strategiesAlternative and integrated testing strategies
Alternative and integrated testing strategies
EFSA EU
 
OECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicityOECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicity
Shital Magar
 
6.drug toxicity and safety
6.drug toxicity and safety 6.drug toxicity and safety
6.drug toxicity and safety
Dr.Manish Kumar
 
Toxicity studies of drug
Toxicity studies of drugToxicity studies of drug
Toxicity studies of drug
Pharmacism
 
Pyrogen testing 112070804005
Pyrogen testing  112070804005Pyrogen testing  112070804005
Pyrogen testing 112070804005Patel Parth
 
Overview of drug toxicity
Overview of drug toxicityOverview of drug toxicity
Overview of drug toxicity
Deepaneeta Sarmah
 
MTT cell proliferation assay
MTT cell proliferation assay MTT cell proliferation assay
MTT cell proliferation assay
Chander K Negi
 
Alternatives to animal experiments
Alternatives to animal experimentsAlternatives to animal experiments
Alternatives to animal experimentsRoopali Somani
 
Pyrogen testing
Pyrogen testingPyrogen testing
Pyrogen testing
nilesh1208
 

Viewers also liked (12)

Skin phototoxicity-of-cosmetic-formulations-containing-photounstable-and-phot...
Skin phototoxicity-of-cosmetic-formulations-containing-photounstable-and-phot...Skin phototoxicity-of-cosmetic-formulations-containing-photounstable-and-phot...
Skin phototoxicity-of-cosmetic-formulations-containing-photounstable-and-phot...
 
Pyrogen and its various test
Pyrogen and its various testPyrogen and its various test
Pyrogen and its various test
 
Alternative and integrated testing strategies
Alternative and integrated testing strategiesAlternative and integrated testing strategies
Alternative and integrated testing strategies
 
OECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicityOECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicity
 
6.drug toxicity and safety
6.drug toxicity and safety 6.drug toxicity and safety
6.drug toxicity and safety
 
Toxicity studies of drug
Toxicity studies of drugToxicity studies of drug
Toxicity studies of drug
 
Carcinogenicity testing
Carcinogenicity testingCarcinogenicity testing
Carcinogenicity testing
 
Pyrogen testing 112070804005
Pyrogen testing  112070804005Pyrogen testing  112070804005
Pyrogen testing 112070804005
 
Overview of drug toxicity
Overview of drug toxicityOverview of drug toxicity
Overview of drug toxicity
 
MTT cell proliferation assay
MTT cell proliferation assay MTT cell proliferation assay
MTT cell proliferation assay
 
Alternatives to animal experiments
Alternatives to animal experimentsAlternatives to animal experiments
Alternatives to animal experiments
 
Pyrogen testing
Pyrogen testingPyrogen testing
Pyrogen testing
 

Similar to Skin eye irritation

Taking the sting out of mildness testing
Taking the sting out of mildness testingTaking the sting out of mildness testing
Taking the sting out of mildness testing
Dr Carol Barker-Treasure
 
OECD Webinar | OECD Alternatives to in vivo eye irritation testing - Chantra ...
OECD Webinar | OECD Alternatives to in vivo eye irritation testing - Chantra ...OECD Webinar | OECD Alternatives to in vivo eye irritation testing - Chantra ...
OECD Webinar | OECD Alternatives to in vivo eye irritation testing - Chantra ...
OECD Environment
 
Safer cosmetics through in vitro science - XCellR8 presentation to Cosmetics ...
Safer cosmetics through in vitro science - XCellR8 presentation to Cosmetics ...Safer cosmetics through in vitro science - XCellR8 presentation to Cosmetics ...
Safer cosmetics through in vitro science - XCellR8 presentation to Cosmetics ...
Susie Lee-Kilgariff
 
Safer cosmetics through in vitro science. XCellR8 presentation to Cosmetics B...
Safer cosmetics through in vitro science. XCellR8 presentation to Cosmetics B...Safer cosmetics through in vitro science. XCellR8 presentation to Cosmetics B...
Safer cosmetics through in vitro science. XCellR8 presentation to Cosmetics B...
Dr Carol Barker-Treasure
 
Silverfernchemical provide you best Glycerin.
Silverfernchemical provide you best Glycerin.Silverfernchemical provide you best Glycerin.
Silverfernchemical provide you best Glycerin.
silverchemical
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
HimikaRathi
 
In vitro skin corrosion test methods
In vitro skin corrosion test methodsIn vitro skin corrosion test methods
In vitro skin corrosion test methods
Dr Carol Barker-Treasure
 
Sterility testing
Sterility testingSterility testing
Sterility testing
Harshali Dhaygude
 
In vitro metjhods for testing immunotoxicity and skin Sensitization-AVRLinkedIN
In vitro metjhods for testing immunotoxicity and skin Sensitization-AVRLinkedINIn vitro metjhods for testing immunotoxicity and skin Sensitization-AVRLinkedIN
In vitro metjhods for testing immunotoxicity and skin Sensitization-AVRLinkedINAn Van Rompay
 
15-3-3XB-21
15-3-3XB-2115-3-3XB-21
Cleaning validation a risk integrated approach
Cleaning validation a risk integrated approachCleaning validation a risk integrated approach
Cleaning validation a risk integrated approach
Sambhujyoti Das
 
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testing
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testingVisual Inspection of Parentetal Drug Products in Pharmaceutical Quality testing
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testing
KarishmaRK
 
Kojic acid dipalmitate msds
Kojic acid dipalmitate msdsKojic acid dipalmitate msds
Kojic acid dipalmitate msds
SHANDONG OCTAGON CHEMICALS LIMITED
 
Eco Clean MSDS
Eco Clean MSDSEco Clean MSDS
Eco Clean MSDS
necicero
 
Sitec Presentation 140915
Sitec Presentation 140915Sitec Presentation 140915
Sitec Presentation 140915Sitec Labs
 
Brodifacoum technical material
Brodifacoum technical materialBrodifacoum technical material
Brodifacoum technical material
KongKing11
 
TinSil® 70-20 Silicone Rubber Part A
TinSil® 70-20 Silicone Rubber Part ATinSil® 70-20 Silicone Rubber Part A
TinSil® 70-20 Silicone Rubber Part A
Polytek Development Corp
 
TinSil® 70-20 Silicone Rubber Part A
TinSil® 70-20 Silicone Rubber Part ATinSil® 70-20 Silicone Rubber Part A
TinSil® 70-20 Silicone Rubber Part A
Polytek Development Corp
 
MicroPRO, A Rapid Microbiology Method Based on Flow Cytometry
MicroPRO, A Rapid Microbiology Method Based on Flow CytometryMicroPRO, A Rapid Microbiology Method Based on Flow Cytometry
MicroPRO, A Rapid Microbiology Method Based on Flow Cytometry
guest32bcc5
 

Similar to Skin eye irritation (20)

Taking the sting out of mildness testing
Taking the sting out of mildness testingTaking the sting out of mildness testing
Taking the sting out of mildness testing
 
OECD Webinar | OECD Alternatives to in vivo eye irritation testing - Chantra ...
OECD Webinar | OECD Alternatives to in vivo eye irritation testing - Chantra ...OECD Webinar | OECD Alternatives to in vivo eye irritation testing - Chantra ...
OECD Webinar | OECD Alternatives to in vivo eye irritation testing - Chantra ...
 
AnVan Rompay
AnVan RompayAnVan Rompay
AnVan Rompay
 
Safer cosmetics through in vitro science - XCellR8 presentation to Cosmetics ...
Safer cosmetics through in vitro science - XCellR8 presentation to Cosmetics ...Safer cosmetics through in vitro science - XCellR8 presentation to Cosmetics ...
Safer cosmetics through in vitro science - XCellR8 presentation to Cosmetics ...
 
Safer cosmetics through in vitro science. XCellR8 presentation to Cosmetics B...
Safer cosmetics through in vitro science. XCellR8 presentation to Cosmetics B...Safer cosmetics through in vitro science. XCellR8 presentation to Cosmetics B...
Safer cosmetics through in vitro science. XCellR8 presentation to Cosmetics B...
 
Silverfernchemical provide you best Glycerin.
Silverfernchemical provide you best Glycerin.Silverfernchemical provide you best Glycerin.
Silverfernchemical provide you best Glycerin.
 
Regulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studiesRegulatory guidelines for conducting toxicity studies
Regulatory guidelines for conducting toxicity studies
 
In vitro skin corrosion test methods
In vitro skin corrosion test methodsIn vitro skin corrosion test methods
In vitro skin corrosion test methods
 
Sterility testing
Sterility testingSterility testing
Sterility testing
 
In vitro metjhods for testing immunotoxicity and skin Sensitization-AVRLinkedIN
In vitro metjhods for testing immunotoxicity and skin Sensitization-AVRLinkedINIn vitro metjhods for testing immunotoxicity and skin Sensitization-AVRLinkedIN
In vitro metjhods for testing immunotoxicity and skin Sensitization-AVRLinkedIN
 
15-3-3XB-21
15-3-3XB-2115-3-3XB-21
15-3-3XB-21
 
Cleaning validation a risk integrated approach
Cleaning validation a risk integrated approachCleaning validation a risk integrated approach
Cleaning validation a risk integrated approach
 
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testing
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testingVisual Inspection of Parentetal Drug Products in Pharmaceutical Quality testing
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testing
 
Kojic acid dipalmitate msds
Kojic acid dipalmitate msdsKojic acid dipalmitate msds
Kojic acid dipalmitate msds
 
Eco Clean MSDS
Eco Clean MSDSEco Clean MSDS
Eco Clean MSDS
 
Sitec Presentation 140915
Sitec Presentation 140915Sitec Presentation 140915
Sitec Presentation 140915
 
Brodifacoum technical material
Brodifacoum technical materialBrodifacoum technical material
Brodifacoum technical material
 
TinSil® 70-20 Silicone Rubber Part A
TinSil® 70-20 Silicone Rubber Part ATinSil® 70-20 Silicone Rubber Part A
TinSil® 70-20 Silicone Rubber Part A
 
TinSil® 70-20 Silicone Rubber Part A
TinSil® 70-20 Silicone Rubber Part ATinSil® 70-20 Silicone Rubber Part A
TinSil® 70-20 Silicone Rubber Part A
 
MicroPRO, A Rapid Microbiology Method Based on Flow Cytometry
MicroPRO, A Rapid Microbiology Method Based on Flow CytometryMicroPRO, A Rapid Microbiology Method Based on Flow Cytometry
MicroPRO, A Rapid Microbiology Method Based on Flow Cytometry
 

More from crovida

Scip notification
Scip notificationScip notification
Scip notification
crovida
 
Printout webinar r ax costanza 05 05-2020
Printout webinar r ax costanza 05 05-2020Printout webinar r ax costanza 05 05-2020
Printout webinar r ax costanza 05 05-2020
crovida
 
Investigative toxicology
Investigative toxicologyInvestigative toxicology
Investigative toxicology
crovida
 
Evoluzione ricerca scientifica
Evoluzione ricerca scientificaEvoluzione ricerca scientifica
Evoluzione ricerca scientifica
crovida
 
NAMs reach and reproductive toxicity
NAMs reach and reproductive toxicityNAMs reach and reproductive toxicity
NAMs reach and reproductive toxicity
crovida
 
Corso caltanissetta 08 02-2019
Corso caltanissetta 08 02-2019Corso caltanissetta 08 02-2019
Corso caltanissetta 08 02-2019
crovida
 
Endocrine disruptors efsa ngo 2019
Endocrine disruptors efsa ngo 2019Endocrine disruptors efsa ngo 2019
Endocrine disruptors efsa ngo 2019
crovida
 
Poster rovida lorenzetti v2.0
Poster rovida lorenzetti v2.0Poster rovida lorenzetti v2.0
Poster rovida lorenzetti v2.0
crovida
 
ecopa, The European Consensus Platform for 3R Alternatives to Animal Experime...
ecopa, The European Consensus Platform for 3R Alternatives to Animal Experime...ecopa, The European Consensus Platform for 3R Alternatives to Animal Experime...
ecopa, The European Consensus Platform for 3R Alternatives to Animal Experime...
crovida
 
7. costanza rovida in vitro development of alternative testing from monolayer...
7. costanza rovida in vitro development of alternative testing from monolayer...7. costanza rovida in vitro development of alternative testing from monolayer...
7. costanza rovida in vitro development of alternative testing from monolayer...
crovida
 
NAMs in biomedical research
NAMs in biomedical researchNAMs in biomedical research
NAMs in biomedical research
crovida
 
Metodi alternativi sostitutivi del XXI secolo
Metodi alternativi sostitutivi del XXI secoloMetodi alternativi sostitutivi del XXI secolo
Metodi alternativi sostitutivi del XXI secolo
crovida
 
Endocrine disruptors as they are regulated in the EU
Endocrine disruptors as they are regulated in the EUEndocrine disruptors as they are regulated in the EU
Endocrine disruptors as they are regulated in the EU
crovida
 
La rivoluzione REACH
La rivoluzione REACHLa rivoluzione REACH
La rivoluzione REACH
crovida
 

More from crovida (14)

Scip notification
Scip notificationScip notification
Scip notification
 
Printout webinar r ax costanza 05 05-2020
Printout webinar r ax costanza 05 05-2020Printout webinar r ax costanza 05 05-2020
Printout webinar r ax costanza 05 05-2020
 
Investigative toxicology
Investigative toxicologyInvestigative toxicology
Investigative toxicology
 
Evoluzione ricerca scientifica
Evoluzione ricerca scientificaEvoluzione ricerca scientifica
Evoluzione ricerca scientifica
 
NAMs reach and reproductive toxicity
NAMs reach and reproductive toxicityNAMs reach and reproductive toxicity
NAMs reach and reproductive toxicity
 
Corso caltanissetta 08 02-2019
Corso caltanissetta 08 02-2019Corso caltanissetta 08 02-2019
Corso caltanissetta 08 02-2019
 
Endocrine disruptors efsa ngo 2019
Endocrine disruptors efsa ngo 2019Endocrine disruptors efsa ngo 2019
Endocrine disruptors efsa ngo 2019
 
Poster rovida lorenzetti v2.0
Poster rovida lorenzetti v2.0Poster rovida lorenzetti v2.0
Poster rovida lorenzetti v2.0
 
ecopa, The European Consensus Platform for 3R Alternatives to Animal Experime...
ecopa, The European Consensus Platform for 3R Alternatives to Animal Experime...ecopa, The European Consensus Platform for 3R Alternatives to Animal Experime...
ecopa, The European Consensus Platform for 3R Alternatives to Animal Experime...
 
7. costanza rovida in vitro development of alternative testing from monolayer...
7. costanza rovida in vitro development of alternative testing from monolayer...7. costanza rovida in vitro development of alternative testing from monolayer...
7. costanza rovida in vitro development of alternative testing from monolayer...
 
NAMs in biomedical research
NAMs in biomedical researchNAMs in biomedical research
NAMs in biomedical research
 
Metodi alternativi sostitutivi del XXI secolo
Metodi alternativi sostitutivi del XXI secoloMetodi alternativi sostitutivi del XXI secolo
Metodi alternativi sostitutivi del XXI secolo
 
Endocrine disruptors as they are regulated in the EU
Endocrine disruptors as they are regulated in the EUEndocrine disruptors as they are regulated in the EU
Endocrine disruptors as they are regulated in the EU
 
La rivoluzione REACH
La rivoluzione REACHLa rivoluzione REACH
La rivoluzione REACH
 

Recently uploaded

EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
AlguinaldoKong
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
AADYARAJPANDEY1
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
muralinath2
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
yusufzako14
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
IqrimaNabilatulhusni
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
Sérgio Sacani
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
sonaliswain16
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Health Advances
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
anitaento25
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
ossaicprecious19
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Ana Luísa Pinho
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
Richard Gill
 

Recently uploaded (20)

EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
insect taxonomy importance systematics and classification
insect taxonomy importance systematics and classificationinsect taxonomy importance systematics and classification
insect taxonomy importance systematics and classification
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
 
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
Deep Behavioral Phenotyping in Systems Neuroscience for Functional Atlasing a...
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 

Skin eye irritation

  • 1. Strategie di test per la valutazione di skin e eye irritation Costanza Rovida CAAT Europe REACH mastery costanza.rovida@chimici.it Slide 1 of 60
  • 3. Slide 2 of 60 www.echemportal.org Tipo di test eseguito 170 228 188 142 166 168 296 134 38 29 48 133 365 152 350 167 0 100 200 300 400 500 600 700 2006 2007 2008 2009 2010 2011 2012 2013 Skin corrosion/irritation in vivo in vitro
  • 4. Slide 2 of 60 www.echemportal.org Tipo di test eseguito 144 216 160 109 312 167 284 169 12 21 38 91 268 117 284 139 0 50 100 150 200 250 300 350 2006 2007 2008 2009 2010 2011 2012 2013 in vivo in vitro Eye corrosion/irritation
  • 5. I risultati negativi di un test in vitro non sono accettati dagli enti regolatori e vanno obbligatoriamente sempre confermati in vivo
  • 6. 1.4. In vitro methods ……. If the results obtained from the use of such in vitro methods do not indicate a certain dangerous property, the relevant test shall nevertheless be carried out at the appropriate tonnage level to confirm the negative result, unless testing is not required in accordance with Annexes VII to X or the other rules in this Annex. Such confirmation may be waived, if the following conditions are met: (1) results are derived from an in vitro method whose scientific validity has been established by a validation study, according to internationally agreed validation principles; (2) results are adequate for the purpose of classification and labelling and/or risk assessment; and (3) adequate and reliable documentation of the applied method is provided.
  • 8. Other official documents http://echa.europa.eu/documents/10162/21650280/oecd_test_guidelines_skin_irritation_en.pdf Report EUR 26797 EN http://publications.jrc.ec.europa.eu/repository/handle/111111111/32662
  • 9. OECD 404: Description of the evaluation and testing strategy • Step 1: Evaluation of existing human and animal data • Step 2: Analysis of structure activity relationships (SAR) • Step 3: Physicochemical properties and chemical reactivity • Step 4: Dermal toxicity • Step 5 and 6: Results from in vitro or ex vivo tests • Step 6 and 7: In vivo test in rabbits Slide 4 of 60
  • 10. 1. Human data: a. Occupational exposure b. (consumer exposure) 2. Old animal data: a. Impurities b. GLP Valutazione dei dati esistenti
  • 11. Raccolta di tutte le informazioni disponibili • Step 3: Physicochemical properties and chemical reactivity • Step 4: Dermal toxicity (and other data)
  • 13. Analisi della structure activity relationships (SAR) Proprietà chimico-fisiche e reattività chimica
  • 14. Slide 5 of 60 Skin irritation Eye irritation Not irritant Not irritant Category 2 – H315 Causes skin irritation Category 2 – H319 Causes serious eye irritation Category 1 – H314 Causes severe skin burns and eye damage Category 1 – H318 Causes serious eye damage Category 1A / 1B / 1C (Packing group I, II, III)1 Skin irritation Eye irritation Not irritant Not irritant Not irritant Category 2 - H319 Causes serious eye irritation Category 2 – H315 Causes skin irritation Category 2 - H319 Causes serious eye irritation Category 2 – H315 Causes skin irritation Category 1- H318 Causes serious eye damage Category 1 – H314 Causes severe skin burns and eye damage
  • 15. • I dati esistenti, le proprietà chimico-fisiche (sperimentali o stimate) e lo studio SAR permettono una previsione preliminare della possibilita per una sostanza di essere irritante o corrosiva per la pelle e per gli occhi. Slide 5 of 60 CORROSIVO? IRRITANTE? TOP DOWN APPROACH (irritation category) BOTTOM UP APPROACH Top Down e Bottom up
  • 17. Esempio: Thioanisole methyl phenyl sulphide EC 202-878-2 CAS 100-68-5
  • 19. Thioanisole and similar substances: Anisole EUH066 (repeated exposure may cause skin dryness or cracking) Observed in an in vivo skin irritation study.
  • 20. Thioanisole: mild irritant? As described in the ECHA database Guideline B46: In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test GLP Study Test substance: 10 µL undiluted Duration of treatment: 15 minutes followed by washing and incubation for 42 hours at 37°C Test animal: human Species and strain, number of animals: not relevant control animals: Other, negative control tissues treated with PBS; positive control tissues treated with 5% SDS Results: The relative mean tissue viability obtained after 15 minutes treatment compared to the negative controls was 11% (< 50%) H315: Causes skin irritation
  • 21. Thioanisole: eye irritant? As described in the ECHA database OECD Guideline 437: Bovine Corneal Opacity and Permeability (BCOP) GLP Study Test substance: 750 µL undiluted Duration of treatment: 10 minutes Test animal: Bovine Species and strain, number of animals: not relevant Results: IVS range from 2.9 and 4.8, average 3.9 H318: Causes eye irritation I risultati del BCOP sono molto vicini alla non classificazione. Questo, in teoria, dovrebbe indurre nuovi test di valutazione. Tuttavia, questa sostanza è già classificata irritante per la pelle.
  • 22. Thioanisole: corrosive? As described in the ECHA database Guideline B40: In Vitro Skin corrosion: In vitro Skin Corrosion: Human Skin Model Test GLP Study Test substance: 50 µL undiluted Duration of treatment: 3 minutes and 1 hour Test animal: human Species and strain: not relevant number of animals: 4 tissues Results: 3 minutes: viability 50% 1 hour: viability 59% Not Corrosive, Classification H315 confirmed
  • 23. Conclusions Considerare le richieste regolatorie Non esiste una strategia universale: anche la valutazione più semplice va adattata alla sostanza (miscela) specifica e ad un determinato uso, nonchè ambito di applicazione. La valutazione di una sostanza va fatta in modo globale, e non endpoint per endpoint Le conclusioni sono una valutazione di tutti I dati disponibili, e non solo una mera somma delle conclusioni dei singoli studi. Un occhio anche ai costi e alla semplificazione dell'approccio Ancora troppo basata sul giudizio degli esperti

Editor's Notes

  1. The eChemPortal is an effort of the Organisation for Economic Co-operation and Development (OECD) in collaboration with the European Commission, the European Chemicals Agency, the United States, Canada, Japan, the International Council of Chemical Associations, the Business and Industry Advisory Committee, the World Health Organization's International Program on Chemical Safety, the United Nations Environment Programme on Chemicals and environmental non-governmental organisations.
  2. Results obtained from suitable in vitro methods may indicate the presence of a certain dangerous property or may be important in relation to a mechanistic understanding, which may be important for the assessment. In this context, ‘suitable’ means sufficiently well developed according to internationally agreed test development criteria (e. g. the European Centre for the Validation of Alternative Methods (ECVAM)) criteria for the entry of a test into the prevalidation process). Depending on the potential risk, immediate confirmation requiring testing beyond the information foreseen in Annexes VII or VIII or proposed confirmation requiring testing beyond the information foreseen in Annexes IX or X for the respective tonnage level may be necessary.
  3. This report was vpublished by ECHA.
  4. My complain is for missing dedicated pages in IUCLID
  5. Even if I claim to apply OECD 404, I must follow those steps as explicitely requested by the guideline
  6. Human tests (50-60s) Study reports Report from Occupational Doctor (interview of workers) even if that is not useful for regulatory purposes, it is very important as it provides the idea of the real property of the substance For the moment, it never happened to receive in vitro existing results. Let's see in the near future
  7. Read across, but not only
  8. there is usually no strict NOAEL or NOAEC identified in studies on irritation, corrosion, or sensitisation. Therefore, in many, or even most cases, the lack of NOAEL(C), dose-response or indication of potency will require that a more qualitative approach is followed
  9. No ex vivo If there are "results" I've found them already No TESTS, but test, because we want to perform only one
  10. IVS: in vitro irritancy scores
  11. Wikipedia is also useful Under the test conditions of this study, Anisole was slightly irritating to the rabbit skin. The mean score over 24, 48 and 72 hours for individual animals was 1.7, 1.7 and 2.3 for erythema and 1.3, 1.3 and 1.3 for oedema. These cutaneous reactions were fully reversible within 7 days. Based on these results, no classification is required according to the EU legislation (CLP regulation (1272/2008) and Directive 67/548/EEC). In a primary dermal irritation study performed according to the OECD guideline No. 404 and in compliance with the GLP, three male New Zealand rabbits were dermally exposed to 0.5 mL of undiluted Anisole for 4 hours under a semi-occlusive dressing. Cutaneous reactions were observed approximately 1 hour, 24 and 72 hours after removal of the dressing and then daily until day 15. The mean values of the scores for erythema and oedema were calculated for each animal. Moderate reversible cutaneous reactions were observed after removal of the dressing applied during 4 hours. They consisted of erythema (scores of 1 to 3) and oedema (scores of 2). The mean score over 24, 48 and 72 hours for individual animals was 1.7, 1.7 and 2.3 for erythema and 1.3, 1.3 and 1.3 for oedema. By day 7, no erythema nor oedema were observed. Between days 5 and 15, a dryness of the skin was observed at the treatment site of the three animals. No ulceration or necrosis was noted. Under the test conditions of this study, Anisole is considered as slightly irritating to skin. However, according to the classification criteria laid down in Regulation (EC) 1272/2008 (CLP) and in Council Directive 67/548/EEC (and subsequent adaptations), the test item should not be classified as irritating to the skin. This skin irritation study is classified as acceptable. It satisfies the guideline requirement for a skin irritation in the rabbit.
  12. There is no clue for a possible severe irritation
  13. There is no clue for a possible severe irritation To conclude: mild result of the BCOP test supports the hypothesis that thioanisole is not corrosive Skin irritant test makes further investigation on eye irritation useless We are talking about an intermediate: it's neither a topical cream nor an eye drops